Rohto Pharmaceutical Announces Increase in Dividend to 25 Yen ｜ May 2026

Dividend Decision and Details

Rohto Pharmaceutical has decided to pay a dividend of 25 yen per share for the fiscal year ending March 2026, with a total amount of 5,649 million yen. The dividend will be effective from June 8, 2026, representing an increase from the previous year's 20 yen. The increase in dividends indicates a strengthening of shareholder returns, utilizing retained earnings as the source.

Future Shareholder Returns and Outlook

The increase in dividend reflects a commitment to stronger shareholder returns. While future forecasts and outlook are not detailed in the material, there is an indication of continued stable and increased dividends. Investors may focus on the company's stable dividend policy and ongoing shareholder return initiatives.